USE OF THROMBOPOYETIN AS A MEDICINAL PRODUCT FOR THERAPY AND THE PREVENTION OF THROMBOCYTOPENIA.

摘要

Use of a thrombopoietin for the manufacture of a medicament for the treatment of a mammal suffering from thrombocytopenia or at risk of suffering from it, characterized in that the medication is administered in the form of two therapeutic doses in a single day, wherein said therapeutic dose ranges between 0.5 and 1.5 cups / kg each, in a two-dose administration, without supplementary treatment with thrombopoietin, or in the form of a single therapeutic dose, without supplementary treatment with thrombopoietin, where thrombocytopenia is generated by Chemotherapy or radiotherapy.